BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7159053)

  • 1. [Value of the pentagastrin test in familial hypercalcitoninemia].
    Bodson A; Becquevort P; Dwelshauvers J; Demol H; Michel L; Alexandre GP; Vanderbeck L
    Ann Endocrinol (Paris); 1982; 43(4):299-300. PubMed ID: 7159053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medullary carcinoma of the thyroid. (Clinical and endocrinological features of six cases).
    degli Uberti EC; Trasforini G; Bagni B; Liboni A; Pansini GC; Altavilla G
    Ric Clin Lab; 1981; 11(2):171-8. PubMed ID: 7268276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of provocative tests in suspected medullary carcinoma of the thyroid:heterogeneity of calcitonin responses to calcium and pentagastrin.
    McLean GW; Rabin D; Moore L; Deftos LJ; Lorber D; McKenna TJ
    Metabolism; 1984 Sep; 33(9):790-6. PubMed ID: 6472115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MEN 2A syndrome: report of a family].
    Krassowski J; Gabryelewicz MB; Jeske W; Zgliczyński S
    Pol Merkur Lekarski; 2000 Jul; 8(49):481-2. PubMed ID: 11070721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A familial case of multiple endocrine neoplasia (MEN IIb). Diagnosis of medullary thyroid cancer].
    Rochiccioli P; Tauber MT; Pienkowski C
    J Genet Hum; 1989 Sep; 37(3):207-14. PubMed ID: 2576280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening for the familial form of medullary cancer of the thyroid].
    Allannic H
    Bull Cancer; 1984; 71(2):125-9. PubMed ID: 6733292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma.
    Verdy M; Cholette JP; Cantin J; Lacroix A; Sturtridge WC
    Can Med Assoc J; 1978 Jul; 119(1):29-35. PubMed ID: 679097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for medullary carcinoma of the thyroid in families with Sipple's syndrome: evaluation of new stimulation tests.
    Telenius-Berg M; Almqvist S; Berg B; Hedner P; Ingemansson S; Tibblin S; Wasthed B
    Eur J Clin Invest; 1977 Feb; 7(1):7-16. PubMed ID: 402280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
    Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
    J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of occult familial medullary carcinoma of the thyroid using pentagastrin.
    Starling JR; Harris C; Granner DK
    Arch Surg; 1978 Mar; 113(3):241-3. PubMed ID: 637688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The early diagnosis of medullary carcinoma of the thyroid gland in patients with multiple endocrine neoplasia type II.
    Wells SA; Ontjes DA; Cooper CW; Hennessy JF; Ellis GJ; McPherson HT; Sabiston DC
    Ann Surg; 1975 Oct; 182(4):362-70. PubMed ID: 1180576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple endocrine neoplasia type II: the role of gastrointestinal humoral factors in calcitonin release following alcohol and pentagastrin stimulation.
    Fletcher DR; Gamvros O; Man WK; Ahmed Y; Trayner I; Adrian T
    Aust N Z J Surg; 1984 Jun; 54(3):271-5. PubMed ID: 6147130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provocative testing for occult medullary carcinoma of the thyroid: findings in seven children with multiple endocrine neoplasia type IIa.
    Graham SM; Genel M; Touloukian RJ; Barwick KW; Gertner JM; Torony C
    J Pediatr Surg; 1987 Jun; 22(6):501-3. PubMed ID: 2886576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medullary carcinoma of the thyroid. An update of diagnostic and prognostic factors.
    Gautvik KM
    Scand J Clin Lab Invest Suppl; 1991; 206():85-92. PubMed ID: 1947764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial nonmultiple endocrine neoplasia medullary thyroid carcinoma: an evolving clinical entity.
    McHenry CR; Oppenheim DS; Murphy T; Broughan T; Vogt D; Goldfarb WB
    Surgery; 1992 Oct; 112(4):728-32; discussion 732-3. PubMed ID: 1411944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The diagnosis of medullary carcinoma of the thyroid (author's transl)].
    Mulder H; Su CA
    Dtsch Med Wochenschr; 1977 Apr; 102(13):479-82. PubMed ID: 844427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial medullary thyroid carcinoma in multiple endocrine neoplasia (MEN) IIa: diagnosis and problems in treatment.
    Emmertsen K; Elbrønd O; Nielsen HE; Mosekilde L; Charles P; Kaae S; Hansen HH
    Eur J Cancer Clin Oncol; 1982 Jul; 18(7):645-50. PubMed ID: 6127216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of pentagastrin injection and calcium infusion as provocative agents for the detection of medullary carcinoma of the thyroid.
    Hennessy JF; Wells SA; Ontjes DA; Cooper CW
    J Clin Endocrinol Metab; 1974 Sep; 39(3):487-95. PubMed ID: 4471967
    [No Abstract]   [Full Text] [Related]  

  • 19. Early diagnosis and treatment of medullary thyroid carcinoma.
    Wells SA; Dilley WG; Farndon JA; Leight GS; Baylin SB
    Arch Intern Med; 1985 Jul; 145(7):1248-52. PubMed ID: 4015274
    [No Abstract]   [Full Text] [Related]  

  • 20. [Early recognition of C-cell carcinoma by family screening (author's transl)].
    Wahl RA; Schmidt-Gayk H; Cordes H; Meybier H; Tschahargane C
    Dtsch Med Wochenschr; 1981 Oct; 106(42):1377-80. PubMed ID: 7285815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.